Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Its segments include Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases and cardiovascular and metabolism. Its products include CARVYKTI (ciltacabtagene autoleucel), DARZALEX (daratumumab), DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), ERLEADA (apalutamide), among others. The MedTech segment develops and manufactures a broad portfolio of products used in cardiovascular, orthopedics, surgery, and vision supporting physicians, hospitals, eye care professionals and healthcare systems across a range of acute and elective procedures. The Cardiovascular portfolio includes electrophysiology products. It is also focused on proprietary Firelink degrader antibody conjugate platform.
Back to dashboard
Company Information
About this company
Key people
Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Tim Schmid
Executive Vice President, Worldwide Chairman of MedTech
Marillyn A. Hewson
Lead Independent Director
Mary Catherine Beckerle
Independent Director
Jennifer A. Doudna
Independent Director
Paula A. Johnson
Independent Director
Hubert Joly
Independent Director
Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Kristen Mulholland
Executive Vice President, Chief Human Resources Officer
Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
James Swanson
Executive Vice President, Chief Information Officer
Vanessa Broadhurst
Executive Vice President - Global Corporate Affairs
Tom Cavanaugh
Executive Vice President, Worldwide Chairman, Innovative Medicine
Elizabeth Forminard
Executive Vice President, Chief Legal Officer
John C. Reed
Executive Vice President - Innovative Medicine, Research and Development
Click to see more
Key facts
- Shares in issue3.12bn
- EPICJNJ
- ISINUS4781601046
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$635.56bn
- Employees138,200
- ExchangeNew York Stock Exchange
- IndexDow Industry, S&P 500, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.